Page last updated: 2024-08-26

bosentan anhydrous and Cardiomyopathy, Restrictive

bosentan anhydrous has been researched along with Cardiomyopathy, Restrictive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfano, D; Argiento, P; CalabrĂ², R; Cotrufo, M; D'Alto, M; Galdieri, N; Maiello, C; Russo, MG; Santoro, G; Sarubbi, B1

Other Studies

1 other study(ies) available for bosentan anhydrous and Cardiomyopathy, Restrictive

ArticleYear
Complex multidrug therapy in a patient with pulmonary hypertension before and after orthotopic heart transplantation. A case report.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:11

    Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Cardiomyopathy, Restrictive; Contraindications; Drug Therapy, Combination; Epoprostenol; Heart Failure; Heart Transplantation; Humans; Hypertension, Pulmonary; Male; Sulfonamides

2007